Dr Reddy's Laboratories
Dr Reddy's Laboratories
Shareholder Return: 3-year average, Sales Growth: 3-year Compounded Annual Growth Rate, Return On Equity: 3-year Return on Equity.
At a Glance
-
Shareholder Return105%
-
Sales Growth15%
-
Return on Equity25 %
Why Super 50
It is one of the highest spenders on research and development in the industry, investing 11.5 percent of its revenue in product development. Over 40 percent of the company's revenue comes from the US market where it has moved up the value chain by launching a niche product range and limited competition products.
